Cantor Fitzgerald Boosts Belite Bio Price Target to $266 on Stronger Pricing Outlook for Tinlarebant
Cantor Fitzgerald has significantly increased its price target on Belite Bio (NASDAQ: BLTE) to $266 from $200, while maintaining an…
Cantor Fitzgerald has significantly increased its price target on Belite Bio (NASDAQ: BLTE) to $266 from $200, while maintaining an…